Results from the TRAPID-AMI clinical study have been published online by the Annals of Emergency Medicine, confirming a novel approach for a more rapid diagnosis of heart attack in patients with acute ...

US physicians who’ve been waiting to get their hands on high-sensitivity troponin tests don’t have to wait any longer. Last week, the US Food and Drug Administration (FDA) gave 510(k) clearance to the ...

A single high-sensitivity cardiac troponin T (hs-cTnT) test with findings below the level of detection, teamed with a nonischemic electrocardiogram (ECG), can identify patients with chest pain in the ...

Roche announced that it has received the 510(k) clearance for its Elecsys Troponin T Gen 5 STAT (TnT Gen 5 STAT) blood test for patients with a suspected heart attack. With this clearance, Roche is ...

Please provide your email address to receive an email when new articles are posted on . Introduction of a high-sensitivity troponin T test in Sweden led to an increased incidence of MI diagnosis, ...

Please provide your email address to receive an email when new articles are posted on . Roche Diagnostics Corp. announced that the FDA has cleared its next-generation troponin T assay for use in ...

A modified algorithm using a high-sensitivity cardiac troponin T (hs-cTnT) assay safely and rapidly ruled out more patients with myocardial infarction in one US emergency department, with more than ...

The current lower limit for detection of plasma troponin T in most commercially available tests is approximately 0.01 μg/l, and levels higher than this value are associated with increased mortality.

Cardiac troponin T is a protein biomarker detectable with a blood test, and it is the preferred biomarker for determining cardiovascular risk. In a new study published in JAMA Cardiology, researchers ...

Roche Holdings AG reported results from its TSIX study which demonstrated that its sixth-generation Troponin T test is accurate at diagnosing heart attacks not only in men but also women. Recently ...

Cardiac troponin concentrations are used to identify patients who would benefit from urgent revascularization for acute coronary syndromes. We hypothesized that they might be used in patients with ...